Brentwood, Tennessee-based IMAC Holdings, Inc., has announced the acquisition of Baton Rouge, Louisiana-based Louisiana Orthopaedic & Sports Rehab Institute.
IMAC Holdings Acquires Louisiana Ortho Business
1 min read Premium comments
Secondary#imacholdings#louisianaorthopaedic&sportsrehabinstitute
Founded in 2015, IMAC Holdings owns and manages health and wellness centers for movement restricting diseases. These centers provide sports medicine, orthopedic care, and life science therapies. IMAC Holdings is made up of three business units: 15 outpatient medical centers which, according to the company, “provide regenerative, orthopedic, and minimally invasive procedures and therapies.” the BACKSPACE; and a clinical research division.
Allen Johnston, M.D. founded the Louisiana Orthopaedic & Sports Rehab Institute in 1988. The business has also been known as Louisiana Orthopedic & Spine Institute. For more than 30 years, Dr. Johnson has served the Baton Rouge community. He will continue to treat patients from his Baton Rouge, Louisiana location.
He will also join IMAC Holdings as a medical director and will, according to IMAC, expand the “company’s in-house expertise in orthopedic and sports medicine.” A graduate of New Orleans, Louisiana-based Louisiana State University School of Medicine, Dr. Johnston specializes in orthopedic and orthopedic trauma surgery.
IMAC Holdings acquired Louisiana Orthopaedic & Sports Rehab Institute “for an undisclosed combination of cash and common stock, consistent with IMAC Holdings historical transaction multiples.”
IMAC CEO Jeff Ervin commented, “We are very pleased to further expand IMAC’s growing footprint into Louisiana where Dr. Allen Johnston and his practice at the Louisiana Orthopaedic & Sports Rehab Institute represent the perfect blend of capabilities, patient coverage, and service excellence to complement IMAC’s service offerings.”
Ervin continued, “This partnership and Dr. Johnston’s new role as medical director are a testament to the continued execution of our model to grow IMAC with outpatient clinics that have compelling fundamentals and growth opportunities. We strongly believe in the value that IMAC provides to its clients, and we embrace the opportunity to extend that value to a new set of orthopedic patients who we believe can benefit from our approach to movement-restricting conditions.”
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.